$5 Ozempic? New study sparks calls for Novo Nordisk to cut prices

While the list price for a monthly supply of Ozempic in the U.S. nears $1,000, new research indicates it could be manufactured for less than $5 per month, sparking calls from lawmakers for Novo Nordisk to lower the price of its blockbuster diabetes and weight loss drug. 

Related

Retirement runway lengthens for some CEOs

Amid an uptick in abrupt CEO exits, some hospital leaders are drawing out their departures. 

Read more

Mercy taps chief legal officer, senior vice president

St. Louis-based Mercy has tapped Jennifer Brown as chief legal officer and senior vice president, effective April 1.

Read more

HCA provided $3.7B in 2023 charity care

Nashville, Tenn.-based HCA Healthcare provided around $3.7 billion in charity care, uninsured discounts and other uncompensated care in 2023, according to its annual impact report. 

Read more

Newsletter

Never miss a thing! Sign up for our newsletter to stay updated.

About

Provider Strategy reports on market developments and insights related to the healthcare provider workforce. Our publication is committed to improving the healthcare professional workforce, utilization of providers, and ultimately supporting thought leadership in workforce innovation.

We are brought to you by the American Association of Provider Compensation Professionals.

Follow